A coactivator of pre-mRNA splicing

  1. Benjamin J. Blencowe,
  2. Robbyn Issner,
  3. Jeffrey A. Nickerson, and
  4. Phillip A. Sharp
  1. Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 USA; Department of Cell Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01655 USA

Abstract

The nuclear matrix antigen recognized by the monoclonal antibody (mAb) B1C8 is a novel serine (S) and arginine (R)-rich protein associated with splicing complexes and is named here SRm160 (SR-related matrix protein of160 kD). SRm160 contains multiple SR repeats, but unlike proteins of the SR family of splicing factors, lacks an RNA recognition motif. SRm160 and a related protein SRm300 (the 300-kD nuclear matrix antigen recognized by mAb B4A11) form a complex that is required for the splicing of specific pre-mRNAs. The SRm160/300 complex associates with splicing complexes and promotes splicing through interactions with SR family proteins. Binding of SRm160/300 to pre-mRNA is normally also dependent on U1 snRNP and is stabilized by U2 snRNP. Thus, SRm160/300 forms multiple interactions with components bound directly to important sites within pre-mRNA. The results suggest that a complex of the nuclear matrix proteins SRm160 and SRm300 functions as a coactivator of pre-mRNA splicing.

Keywords

Footnotes

  • Present addresses: 3C.H. Best Institute, University of Toronto, Toronto, Ontario, Canada, M5G 1L6; 4Ariad Pharmaceuticals, Cambridge, Massachusetts 02139 USA.

  • Corresponding author.

  • E-MAIL sharppa{at}mit.edu; FAX (617) 253-3867.

    • Received September 30, 1997.
    • Accepted January 29, 1998.
| Table of Contents

Life Science Alliance